Alphabet’s Verily Sells Granular Insurance to Elevance Health

The sale marks a strategic shift as Verily narrows its focus on AI-driven healthcare solutions and separates from Google’s infrastructure.

Verily, Alphabet's health technology subsidiary, is selling its stop-loss insurance business, Granular Insurance, to Elevance Health, with terms undisclosed.
Granular Insurance, launched in 2020 with backing from Swiss Re Group, provides self-funded employers with medical stop-loss and reinsurance solutions using proprietary technology.
The decision reflects Verily's ongoing restructuring, including workforce reductions, leadership changes, and a pivot toward AI-focused healthcare initiatives.
Verily has been transitioning away from Google’s infrastructure and plans to fully separate from its parent company by December 2025.
Recent Verily projects include the AI-powered chronic care platform Lightpath, aimed at supporting patients with metabolic health challenges.